Key result
Higher leptin levels are strongly linked to NAFLD, affecting ~48% of patients with prediabetes.
Why the study?
NAFLD significantly increases cardiovascular risk in patients with glucose metabolism alterations, but predictors of NAFLD in prediabetes patients were not well defined.
Cross-Sectional (n=143)
No
p-value: p=0.0001
Leptin levels strongly predict the presence of NAFLD in patients with prediabetes, highlighting a potential biomarker for metabolic and cardiovascular risk stratification.
Leptin was associated with insulin resistance in prediabetes with NAFLD; leaves open its causal role and clinical utility.
Non-alcoholic fatty liver disease (NAFLD) is a component of metabolic syndrome that significantly increases the cardiovascular risk of patients with glucose metabolism alterations. This study identified the prevalence of NAFLD, predictors of NAFLD and explored the link between insulin sensitivity, insulin resistance and leptinemia in 143 patients registered with prediabetes. Abdominal ultrasound was performed, and fasting insulin, postprandial insulin, leptin levels, common clinical/biochemical determinations were assessed. Certain variables that can predict NAFLD existence were determined and it was found that there is a high prevalence of NAFLD in patients with prediabetes. In univariate analysis, statistically significant associations (P<0.05) were found between waist circumference, systolic blood pressure, diastolic blood pressure, triglycerides, HDL-cholesterol, insulin sensitivity, β-cell function, leptin and NAFLD presence. The coefficients for the variables which obtain statistically significant association (P<0.05) are low, except for leptin which is the biochemical parameter that (in both univariate and multivariate analysis) is a strong predictor of NAFLD presence.
No takes yet. Share an insight, caveat, or question.
Vesa et al. (2020) conducted a cross-sectional in Prediabetes and Non-alcoholic fatty liver disease (NAFLD) (n=143). Clinical and biochemical risk factors (including leptin) vs. Patients without NAFLD was evaluated on Presence of NAFLD (p=0.0001). In patients with prediabetes, the prevalence of NAFLD was 48.25%, with increased leptin levels acting as a strong independent predictor of its presence (p=0.0001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: